Dosch et al36 demonstrated that the human IL-1R1 antagonist anakinra significantly reduced IL-6 levels and inhibited STAT3 activation in pancreatic tumors derived from PKT mice. The gene discussed is IL6; the disease is pancreatic neoplasm.